{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:07:48Z","timestamp":1789006068284,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":364,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Diuretic resistance (DR) in heart failure (HF) is associated with worse outcomes. Furoscix\u00ae, a self-administered subcutaneous (sc) furosemide injection administered via on-body infusor, is approved for HF congestion relief. However, its efficacy in patients with DR post-HF hospitalization remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this open-label pilot randomized controlled trial, 70 participants were randomized within 14\u2009days post-HF hospitalization to receive a single dose of 80\u2009mg sc furosemide or home oral dose furosemide. Enrolment was stratified by presence of DR (admission BAN-ADHF score\u2009\u226512) with a 2:1 enrolment of those with versus without DR. Key outcomes included diuretic efficiency, the total urine output per mg of diuretic administered, and peak urine sodium within 8\u2009h of dose administration. Treatment effects were calculated as the difference in estimated marginal means across study groups and DR strata using linear mixed-effect models. Overall, 70 participants were enrolled (57\u2009years, 27% female, 70% Black, 79% with HF with reduced ejection fraction). Participants with DR (n\u2009=\u200946) had worse kidney function, higher N-terminal pro-B-type natriuretic peptide, and higher home diuretic dose. Among participants with DR, sc furosemide versus oral furosemide led to significantly greater diuretic efficiency (34.0 vs. 22.6\u2009ml\/mg, p\u2009=\u20090.002) and peak urine sodium (100 vs. 83\u2009mmol\/L, p\u2009=\u20090.029), while participants without DR had similar diuretic efficiency (29.8 vs. 30.1\u2009ml\/mg, p\u2009=\u20090.94) and peak urine sodium (96 vs. 95\u2009mmol\/L, p\u2009=\u20090.93) across both treatments. DR significantly modified the effect of sc versus oral furosemide on diuretic efficiency (pinteraction: treatment\u2009\u00d7\u2009diuretic resistance\u2009=\u20090.022).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Single-dose sc furosemide was associated with greater diuretic efficiency and peak urine sodium than oral furosemide in participants with DR discharged following recent HF hospitalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3537","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:10:08Z","timestamp":1733119808000},"page":"347-352","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Diuretic Efficiency of a Single Dose of Subcutaneous Versus Oral Furosemide After Heart Failure Hospitalization Across Diuretic Resistance Strata: A Pilot Randomized Controlled Trial"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-8670","authenticated-orcid":false,"given":"Neil","family":"Keshvani","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Rizvi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-0897","authenticated-orcid":false,"given":"Matthew W.","family":"Segar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Texas Heart Institute , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan David","family":"Coellar","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-4096","authenticated-orcid":false,"given":"Kershaw V.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-4651","authenticated-orcid":false,"given":"Bethany","family":"Roehm","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, UT Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[{"name":"Heart, Vascular, and Thoracic Institute, Cleveland Clinic Foundation , Cleveland, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-3836","authenticated-orcid":false,"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center , Dallas, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"2026010913030035200_ejhf3537-bib-0001","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026010913030035200_ejhf3537-bib-0002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"2026010913030035200_ejhf3537-bib-0003","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Diuretic resistance in heart failure","volume":"16","author":"Gupta","year":"2019","journal-title":"Curr Heart Fail Rep"},{"key":"2026010913030035200_ejhf3537-bib-0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2015.05.003","article-title":"Diuretic response in acute heart failure-an analysis from ASCEND-HF","volume":"170","author":"ter Maaten","year":"2015","journal-title":"Am Heart J"},{"key":"2026010913030035200_ejhf3537-bib-0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: Clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"key":"2026010913030035200_ejhf3537-bib-0006","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: Findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"2026010913030035200_ejhf3537-bib-0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/fca-2023-0071","article-title":"Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: The FREEDOM-HF study","volume":"19","author":"Bensimhon","year":"2023","journal-title":"Future Cardiol"},{"key":"2026010913030035200_ejhf3537-bib-0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacbts.2017.10.001","article-title":"Subcutaneous furosemide in heart failure: Pharmacokinetic characteristics of a newly buffered solution","volume":"3","author":"Sica","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2026010913030035200_ejhf3537-bib-0009","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jchf.2023.09.029","article-title":"A phenomapping tool and clinical score to identify low diuretic efficiency in acute decompensated heart failure","volume":"12","author":"Segar","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026010913030035200_ejhf3537-bib-0010","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","article-title":"Natriuresis-guided diuretic therapy in acute heart failure: A pragmatic randomized trial","volume":"29","author":"Ter Maaten","year":"2023","journal-title":"Nat Med"},{"key":"2026010913030035200_ejhf3537-bib-0011","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"2026010913030035200_ejhf3537-bib-0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: The CLOROTIC trial","volume":"44","author":"Trullas","year":"2023","journal-title":"Eur Heart J"},{"key":"2026010913030035200_ejhf3537-bib-0013","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jchf.2024.04.014","article-title":"Diuresis efficacy in ambulatory congested heart failure patients: Intrapatient comparison of 3 diuretic regimens (DEA-HF)","volume":"12","author":"Abbo","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026010913030035200_ejhf3537-bib-0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","article-title":"Diuretic strategies for loop diuretic resistance in acute heart failure: The 3T trial","volume":"8","author":"Cox","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026010913030035200_ejhf3537-bib-0015","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.cardfail.2019.07.213","article-title":"Subcutaneous furosemide in the treatment of patients with decompensated heart failure: Data from the sub-Q pilot studies","volume":"25","author":"Felker","year":"2019","journal-title":"J Card Fail"},{"key":"2026010913030035200_ejhf3537-bib-0016","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jchf.2024.07.015","article-title":"Avoiding treatment in hospital with subcutaneous furosemide for worsening heart failure: A pilot study (AT HOME-HF)","volume":"12","author":"Konstam","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026010913030035200_ejhf3537-bib-0017","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00556898","article-title":"Implications of intraindividual variability in bioavailability studies of furosemide","volume":"27","author":"Grahnen","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"2026010913030035200_ejhf3537-bib-0018","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00630286","article-title":"Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis","volume":"26","author":"Hammarlund","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"2026010913030035200_ejhf3537-bib-0019","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","article-title":"Furosemide absorption altered in decompensated congestive heart failure","volume":"102","author":"Vasko","year":"1985","journal-title":"Ann Intern Med"},{"key":"2026010913030035200_ejhf3537-bib-0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1527-5299.2003.02399.x","article-title":"Pharmacotherapy in congestive heart failure: Drug absorption in the management of congestive heart failure: Loop diuretics","volume":"9","author":"Sica","year":"2003","journal-title":"Congest Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/2\/347\/65347317\/eurjhf_27_2_347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/2\/347\/65347317\/eurjhf_27_2_347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:03:28Z","timestamp":1767981808000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/2\/347\/8322097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,2]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3537","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"2024-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}